West Pharmaceutical Services, Inc. (WST)
NYSE: WST · Real-Time Price · USD
292.13
-10.07 (-3.33%)
Apr 28, 2026, 4:00 PM EDT - Market closed
WST Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 20,638 | 19,795 | 23,723 | 26,053 | 17,424 | 34,744 | Upgrade
|
| Market Cap Growth | 35.47% | -16.56% | -8.95% | 49.53% | -49.85% | 65.89% | Upgrade
|
| Enterprise Value | 20,438 | 19,469 | 23,540 | 25,461 | 16,995 | 34,372 | Upgrade
|
| Last Close Price | 292.13 | 274.68 | 325.95 | 349.56 | 233.09 | 463.39 | Upgrade
|
| PE Ratio | 39.04 | 40.09 | 48.15 | 43.91 | 29.74 | 52.50 | Upgrade
|
| Forward PE | 33.48 | 36.69 | 45.90 | 42.23 | 34.84 | 53.55 | Upgrade
|
| PS Ratio | 6.41 | 6.44 | 8.20 | 8.83 | 6.04 | 12.27 | Upgrade
|
| PB Ratio | 6.93 | 6.23 | 8.84 | 9.04 | 6.49 | 14.88 | Upgrade
|
| P/TBV Ratio | 7.18 | 6.47 | 9.25 | 9.45 | 6.81 | 15.78 | Upgrade
|
| P/FCF Ratio | 45.06 | 42.22 | 85.83 | 62.86 | 39.65 | 105.09 | Upgrade
|
| P/OCF Ratio | 28.85 | 26.23 | 36.31 | 33.55 | 24.07 | 59.49 | Upgrade
|
| PEG Ratio | 2.51 | 3.06 | 5.25 | 5.39 | 2.31 | 2.37 | Upgrade
|
| EV/Sales Ratio | 6.35 | 6.33 | 8.14 | 8.63 | 5.89 | 12.14 | Upgrade
|
| EV/EBITDA Ratio | 23.49 | 24.03 | 31.43 | 30.19 | 19.22 | 38.58 | Upgrade
|
| EV/EBIT Ratio | 29.48 | 30.48 | 39.66 | 36.05 | 22.25 | 44.72 | Upgrade
|
| EV/FCF Ratio | 44.62 | 41.52 | 85.17 | 61.43 | 38.68 | 103.97 | Upgrade
|
| Debt / Equity Ratio | 0.11 | 0.10 | 0.11 | 0.11 | 0.12 | 0.14 | Upgrade
|
| Debt / EBITDA Ratio | 0.35 | 0.38 | 0.39 | 0.35 | 0.35 | 0.36 | Upgrade
|
| Debt / FCF Ratio | 0.70 | 0.70 | 1.11 | 0.75 | 0.72 | 0.98 | Upgrade
|
| Net Debt / Equity Ratio | -0.07 | -0.15 | -0.07 | -0.19 | -0.21 | -0.19 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.23 | -0.57 | -0.24 | -0.65 | -0.65 | -0.49 | Upgrade
|
| Net Debt / FCF Ratio | -0.44 | -0.99 | -0.65 | -1.31 | -1.31 | -1.32 | Upgrade
|
| Asset Turnover | 0.83 | 0.78 | 0.77 | 0.79 | 0.83 | 0.93 | Upgrade
|
| Inventory Turnover | 4.88 | 4.80 | 4.67 | 4.28 | 4.41 | 4.73 | Upgrade
|
| Quick Ratio | 1.81 | 2.10 | 1.93 | 2.07 | 2.73 | 2.13 | Upgrade
|
| Current Ratio | 2.71 | 3.02 | 2.80 | 2.88 | 3.70 | 2.93 | Upgrade
|
| Return on Equity (ROE) | 19.13% | 16.86% | 17.71% | 21.32% | 23.34% | 31.59% | Upgrade
|
| Return on Assets (ROA) | 11.21% | 10.09% | 9.93% | 11.86% | 13.78% | 15.73% | Upgrade
|
| Return on Invested Capital (ROIC) | 19.97% | 19.66% | 20.14% | 26.35% | 31.89% | 38.14% | Upgrade
|
| Return on Capital Employed (ROCE) | 20.20% | 17.70% | 19.20% | 22.40% | 24.70% | 28.30% | Upgrade
|
| Earnings Yield | 2.63% | 2.49% | 2.08% | 2.28% | 3.36% | 1.91% | Upgrade
|
| FCF Yield | 2.22% | 2.37% | 1.17% | 1.59% | 2.52% | 0.95% | Upgrade
|
| Dividend Yield | 0.30% | 0.31% | 0.25% | 0.22% | 0.31% | 0.15% | Upgrade
|
| Payout Ratio | 11.63% | 12.40% | 12.00% | 9.61% | 9.23% | 7.72% | Upgrade
|
| Buyback Yield / Dilution | 1.12% | 1.36% | 2.13% | 0.66% | 0.66% | -0.66% | Upgrade
|
| Total Shareholder Return | 1.43% | 1.67% | 2.37% | 0.88% | 0.97% | -0.51% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.